13. August 2014

Möller et al., accepted in PLOS ONE

EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells

article accepted in PLOS ONE:

EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.

Yvonne Möller, Martin Siegemund, Sven Beyes, Ricarda Herr, Daniele Lecis, Domenico Delia, Roland Kontermann, Tilman Brummer, Klaus Pfizenmaier, and Monilola A. Olayioye

Institute of Cell Biology and Immunology, University of Stuttgart.
Corresponding author: Institute of Cell Biology and Immunology, University of Stuttgart
monilola.olayioye@izi.uni-stuttgart.de.

Zum Seitenanfang